This modification reversibly increases binding to albumin, which results in protection of liraglutide from degradation by DPP-4 and reduces renal clearance
Some find sleep is impaired on low-calorie days, whilst others find sleep is improved, likely due to an improvement in diet quality and not eating late at night (in the case of TRE)
GLP-1 receptor agonists like semaglutide and tirzepatide suppress appetite by increasing feelings of fullness, which can make eating adequate protein challenging for patients on active therapy
Leden RV, Yauger YJ, Khayrullina G et al (2017) Central Nervous System Injury and Nicotinamide Adenine Dinucleotide Phosphate Oxidase: oxidative stress and therapeutic targets
RELATED: New GLP-1 drugs could suppress desire for more than just food, study suggests Big picture view: The rapid rise in GLP-1 usage continues to align with broader improvements in national health, particularly aiding in lowering obesity rates